Contineum Therapeutics, Inc. (CTNM) stock
CTNMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$9.86+0.08 (+0.82%)
Close on Nov 13, 2026Market cap $370.94MP/E –Yield –
Contineum Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Contineum Therapeutics's total assets was $250.37M at Jun 30, 2026. For fiscal 2025 it was $276.64M, up 30.0% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $276.64M | +30.0% |
| FY2024 | Dec 31, 2024 | $212.85M | +63.2% |
| FY2023 | Dec 31, 2023 | $130.39M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $250.37M | +36.9% |
| Q1 FY2026 | Mar 31, 2026 | $261.35M | +31.8% |
| Q4 FY2025 | Dec 31, 2025 | $276.64M | +30.0% |
| Q3 FY2025 | Sep 30, 2025 | $190.85M | -11.7% |
| Q2 FY2025 | Jun 30, 2025 | $182.89M | -17.4% |
| Q1 FY2025 | Mar 31, 2025 | $198.26M | +60.5% |
| Q4 FY2024 | Dec 31, 2024 | $212.85M | +63.2% |
| Q3 FY2024 | Sep 30, 2024 | $216.03M | – |
| Q2 FY2024 | Jun 30, 2024 | $221.36M | – |
| Q1 FY2024 | Mar 31, 2024 | $123.56M | – |
| Q4 FY2023 | Dec 31, 2023 | $130.39M | – |
See a number that looks wrong?